Eurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, 43204 Reus, Spain.
Eurecat, Centre Tecnològic de Catalunya, Centre for Omic Sciences (COS), Joint Unit Universitat Rovira i Virgili-EURECAT, 43204 Reus, Spain.
Int J Mol Sci. 2022 Feb 25;23(5):2563. doi: 10.3390/ijms23052563.
Chronic inflammation is an important risk factor in a broad variety of physical and mental disorders leading to highly prevalent non-communicable diseases (NCDs). However, there is a need for a deeper understanding of this condition and its progression to the disease state. For this reason, it is important to define metabolic pathways and complementary biomarkers associated with homeostatic disruption in chronic inflammation. To achieve that, male Wistar rats were subjected to intraperitoneal and intermittent injections with saline solution or increasing lipopolysaccharide (LPS) concentrations (0.5, 5 and 7.5 mg/kg) thrice a week for 31 days. Biochemical and inflammatory parameters were measured at the end of the study. To assess the omics profile, GC-qTOF and UHPLC-qTOF were performed to evaluate plasma metabolome; 1H-NMR was used to evaluate urine metabolome; additionally, shotgun metagenomics sequencing was carried out to characterize the cecum microbiome. The chronicity of inflammation in the study was evaluated by the monitoring of monocyte chemoattractant protein-1 (MCP-1) during the different weeks of the experimental process. At the end of the study, together with the increased levels of MCP-1, levels of interleukin-6 (IL-6), tumour necrosis factor alpha (TNF-α) and prostaglandin E2 (PGE2) along with 8-isoprostanes (an indicative of oxidative stress) were significantly increased (p-value < 0.05). The leading features implicated in the current model were tricarboxylic acid (TCA) cycle intermediates (i.e., alpha-ketoglutarate, aconitic acid, malic acid, fumaric acid and succinic acid); lipids such as specific cholesterol esters (ChoEs), lysophospholipids (LPCs) and phosphatidylcholines (PCs); and glycine, as well as N, N-dimethylglycine, which are related to one-carbon (1C) metabolism. These metabolites point towards mitochondrial metabolism through TCA cycle, β-oxidation of fatty acids and 1C metabolism as interconnected pathways that could reveal the metabolic effects of chronic inflammation induced by LPS administration. These results provide deeper knowledge concerning the impact of chronic inflammation on the disruption of metabolic homeostasis.
慢性炎症是多种身心障碍的一个重要危险因素,导致高发的非传染性疾病(NCD)。然而,需要更深入地了解这种状况及其向疾病状态的发展。出于这个原因,定义与慢性炎症中内稳态破坏相关的代谢途径和补充生物标志物非常重要。为此,雄性 Wistar 大鼠接受了腹腔内和间歇性注射生理盐水或递增浓度的脂多糖(LPS)(0.5、5 和 7.5mg/kg),每周三次,共 31 天。在研究结束时测量了生化和炎症参数。为了评估组学谱,进行了 GC-qTOF 和 UHPLC-qTOF 以评估血浆代谢组;使用 1H-NMR 评估尿液代谢组;此外,还进行了 shotgun 宏基因组测序以表征盲肠微生物组。通过监测实验过程中不同周的单核细胞趋化蛋白-1(MCP-1)来评估炎症的慢性程度。在研究结束时,与 MCP-1 水平的升高一起,白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)和前列腺素 E2(PGE2)以及 8-异前列腺素(氧化应激的指示物)的水平显著升高(p 值<0.05)。当前模型中涉及的主要特征是三羧酸(TCA)循环中间体(即α-酮戊二酸、顺乌头酸、苹果酸、富马酸和琥珀酸);脂质,如特定胆固醇酯(ChoE)、溶血磷脂(LPC)和磷脂酰胆碱(PC);以及甘氨酸和 N,N-二甲基甘氨酸,它们与一碳(1C)代谢有关。这些代谢物表明通过 TCA 循环、脂肪酸的β-氧化和 1C 代谢的线粒体代谢是相互关联的途径,这可能揭示了 LPS 给药引起的慢性炎症对代谢稳态的破坏的代谢影响。这些结果提供了关于慢性炎症对代谢稳态破坏影响的更深入的知识。